Stock Analysis
Eastman Chemical Company (EMN) Stock Analysis
Eastman Chemical Company (EMN) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.
Eastman Chemical Company (EMN) currently has an AIQ Score of 45/100, indicating a neutral setup. Value is the strongest factor at 67/100. Momentum is the weakest current factor at 23/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
EMN at a Glance
Crawlable current metrics from the latest market-close stock snapshot.
| Metric | Current |
|---|---|
| Price | $68.11 |
| AIQ Score | 45/100 |
| Overall View | Neutral |
| Technical Analysis Consensus | Strong Sell |
| Market Cap | $8.02B |
| P/E Ratio | 15.31 |
| Forward P/E | — |
| EPS | $1.60 |
| Revenue TTM | $2.51B |
| Dividend Yield | 0.01% |
| Beta | 1.08 |
| Volume | 1.52M |
| 52-week range | $56.11-$83.47 |
| RSI 14 | 27.88 |
| 50-Day SMA | $70.70 |
| 200-Day SMA | $70.82 |
| Analyst Price Target | $82.00 |
| Next Earnings | Nov 2, 2026 |
EMN
OverviewEMN Stock Analysis Summary
Eastman Chemical Company (EMN) currently has an AIQ Score of 45/100, indicating a neutral setup. Value is the strongest factor at 67/100. Momentum is the weakest current factor at 23/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
In a neutral regime, EMN has AIQ Score of 45/100 with Value base of 67/100 and fading Momentum at 23/100. Wait for component alignment before adding exposure.
Value (67/100) leads while Momentum (23/100) lags. This cross-factor spread creates entry timing uncertainty.
Basic Materials · -0.39% stock move · EMN classified in Chemicals - Specialty.
Current Evidence
AlgovestIQ Evidence Summary
Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.
Is EMN Bullish or Bearish Right Now?
EMN currently has a neutral overall setup. Value is the strongest factor at 67/100, while Momentum is weakest at 23/100. The current evidence suggests a mixed rather than strongly bullish or bearish setup.
- - Risk Resilience is supportive at 62/100.
- - Analyst target implies +20.39% upside from the latest quote.
- - Momentum is weak at 23/100.
- - Price is -3.82% below its 200-day SMA.
- - Technical consensus has more sell votes than buy votes (37 vs 7).
Current Consensus
EMN's Technical Analysis Consensus is currently Strong Sell, with 7 buy, 1 neutral, and 37 sell votes. EMN's 14-day RSI is 27.88, which places the stock in an oversold momentum range. EMN's beta is 1.08, indicating market sensitivity broadly in line with the market.
What Changed in EMN?
Recent score-change history is not available in the current snapshot. These are the latest market-close scores instead.
What Would Change the EMN Outlook?
The current neutral outlook could improve if AIQ moves above 70, momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 40, price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.
AIQ > 70, RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.
AIQ below 40, RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.
EMN Decision Framework
Public evidence layers, setup checks, and risk context for Eastman Chemical Company.
Eastman Chemical Company (EMN) Stock Analysis
Eastman Chemical Company has an AIQ Score of 45/100 in a Neutral regime. Value is strongest at 67/100. Beta is 1.08, close to market sensitivity. Review the supporting stock factors together before drawing a conclusion from any single score.
| Evidence Layer | Public Evidence |
|---|---|
| Regime Context | EMN is in a Neutral AIQ regime with score 45/100. |
| Signal Conflict | The primary conflict is that value leads at 67/100 while momentum lags at 23/100. |
| Factor Evidence | Momentum 23/100 · Value 67/100 · Quality 34/100 · Risk 62/100 |
| Persistence | Current snapshot evidence is shown; historical persistence remains in AIQ Pro. |
Current Setup Checklist
Value is the strongest factor at 67/100.
Momentum is 23/100 and RSI (14) is 27.9.
EMN is in a Neutral regime at 45/100.
Risk factor is 62/100 with beta 1.08 and annual volatility 33.29%.
Current conflict: value leads at 67/100 while momentum lags at 23/100.
EMN Research Cluster
Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.
EMN Fundamentals
EMN valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.
EMN Technical Analysis
EMN technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.
EMN Stock Catalysts
Track EMN earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.
EMN Dividend Analysis
EMN dividend yield, annual dividend, payout ratio, payment history, and income reliability context.
EMN Financial Data
EMN revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.
EMN Risk Analysis
EMN volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.
EMN Stock News
EMN stock news, market tone, recent headlines, and catalyst context.
EMN vs Chemicals Peers
Current peer cohort: EMN · HUN · IFF · KWR · LIN. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.
| Peer | AIQ | Value | Momentum | Risk | Sharpe | 1Y Volatility | Compare |
|---|---|---|---|---|---|---|---|
| EMN Current stock | 45/100 | 67/100 | 23/100 | 62/100 | 0.19 | 33.29% | Current |
| HUN Huntsman | 42/100 | 65/100 | 34/100 | 49/100 | 0.04 | 60.74% | EMN vs HUN |
| IFF International Flavors & Fragrances | 54/100 | 54/100 | 57/100 | 73/100 | 0.79 | 35.83% | EMN vs IFF |
| KWR Quaker Chemical | 47/100 | 57/100 | 30/100 | 63/100 | 0.39 | 38.06% | EMN vs KWR |
| LIN Linde | 42/100 | 34/100 | 20/100 | 62/100 | -0.18 | 19.27% | EMN vs LIN |
Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Sep 11, 2026.
About the AIQ Score
Methodology for the current stock evidence.
The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.
View AIQ methodologyFactor Diagnostics
A compact bridge from the AIQ score to the evidence tabs.
Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.
AIQ Component Profile
Compare the five component scores on one consistent 0–100 scale.
Review earnings timing, revisions, news pressure, and prior event reactions in one place.
Open catalysts8 recent quarterly periods are available for review.
Checked Sep 12, 2026
Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.
Fundamentals Verdict
Current snapshot fields are separate from reported-quarter statement tables.
Latest period Jun 30, 2026.
Market Confirmation
Technicals are summarized first, with the indicator library behind it.
Risk Alignment
Higher resilience is stronger; exposure metrics stay separate.
Continue Researching EMN
Open the detailed evidence pages and workflows behind the stock overview read.
Premium Feature
Full AIQ Analysis
AIQ Intelligence
AIQ Pro for EMN
Scenario Analysis
AIQ Scenario Builder
Portfolio Implication
Related Links
EMN Stock FAQ
What is EMN stock price today?
Eastman Chemical Company's current stock price is $68.11. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.
Is EMN bullish or bearish right now?
EMN's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.
What is EMN's market cap?
EMN's market cap is $8.02B based on the latest completed market-close snapshot from Sep 11, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.
What is EMN's current P/E ratio?
EMN's current P/E ratio is 15.31 based on the latest completed market-close snapshot from Sep 11, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.
What is EMN's RSI?
EMN's 14-day RSI is 27.88 based on the latest completed market-close snapshot from Sep 11, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.
Is EMN above its 50-day and 200-day moving averages?
EMN is -3.66% from its 50-day SMA and -3.82% from its 200-day SMA based on the latest completed market-close snapshot from Sep 11, 2026. Moving-average position should be read with momentum and broader AIQ evidence.
When is EMN's next earnings date?
EMN's next earnings date is currently listed as Nov 2, 2026. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.
Does EMN pay a dividend?
EMN's dividend yield is 0.01% based on the latest completed market-close snapshot from Sep 11, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.